AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.

Create a link to this page

Copy and paste this link tag into your Web page or blog:

<a href="http://www.accessmylibrary.com/coms2/summary_0286-5185610_ITM" title="Facts and information about Deal signed with Tulane for potential anticancer agents.">Deal signed with Tulane for potential anticancer agents.</a>

Close Set up an RSS feed that alerts you when new articles from Biotech Week are available.

Frequently asked questions about RSS feeds

Deal signed with Tulane for potential anticancer agents.

Biotech Week

| November 24, 2004 | COPYRIGHT 2009 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)Copyright

2004 NOV 24 - (NewsRx.com & NewsRx.net) -- AEterna Zentaris, Inc., (AEZ; AEZS) announced that it has entered into a license and collaboration agreement with Tulane University, in New Orleans, for the development of Growth Hormone Releasing Hormone (GH-RH) antagonists, a novel class of potential anticancer agents.

Under the terms of the agreement, AEterna Zentaris obtained worldwide, exclusive rights to develop and commercialize GH-RH antagonists for all potential indications, including cancer and endocrine disorders, in exchange for research funding, an upfront fee and milestone payments, in addition to royalties on future sales.

GH-RH antagonists represent a…

View articles courtesy of your local library

Related articles from newspapers, magazines, journals, and more


AEterna Zentaris Enters Into a License and Collaboration Agreement With Tulane...: Press release article from: PR Newswire Europe October 27, 2004 700+ words
...Hormone Releasing Hormone (GH-RH) antagonists...terms of the agreement, AEterna Zentaris obtained worldwide...develop and commercialise GH-RH antagonists for...Executive Officer of AEterna Zentaris. GH-RH is a hormone secreted...


AEterna Zentaris Enters into a License and Collaboration Agreement with Tulane...: Press release article from: PR Newswire October 27, 2004 700+ words
...Hormone Releasing Hormone (GH-RH) antagonists...terms of the agreement, AEterna Zentaris obtained worldwide...develop and commercialize GH-RH antagonists for...Executive Officer of AEterna Zentaris. GH-RH is a hormone secreted...


AEterna Zentaris to Present First In Vivo Data on Ghrelin Antagonists' Capacity...: Press release article from: PR Newswire October 19, 2006 700+ words
...FirstCall/ -- AEterna Zentaris Inc. (TSX: AEZ...affecting growth hormone (GH) secretion. The...Operating Officer at AEterna Zentaris. "We are pleased...disclosure of results from AEterna Zentaris' program on ghrelin...


AEterna Laboratories Holds 2004 Annual Shareholder Meeting and Announces...: Press release article from: PR Newswire May 26, 2004 700+ words
...s new corporate name, AEterna Zentaris Inc., as approved by shareholders...respect, the new identity AEterna Zentaris better reflects our Company...Inc. changes its name to AEterna Zentaris Inc. Marketed Products...Partnered with Solvay - GH secretagogue - Advanced to...


AEterna Zentaris Acquires All Assets from Ardana for Growth Hormone...: News wire article from: The America's Intelligence Wire June 8, 2009 700+ words
...8 /CNW Telbec/ - AEterna Zentaris Inc. (NASDAQ: AEZS...President and CEO of AEterna Zentaris. "Our product portfolio...diagnostic test for adult GH deficiency", G...Washington, DC . About AEterna Zentaris Inc. AEterna Zentaris...


AEterna Zentaris acquires all assets from Ardana for growth hormone...: News wire article from: Chemical Business Newsbase June 8, 2009 700+ words
AEterna Zentaris Inc reported that after regaining from...as a simple diagnostic test for adult GH deficiency, presents the first clinical...patients from normal control subjects. AEterna Zentaris Inc is a global biopharmaceutical company...


AEterna Zentaris Announces Details of Distribution of its Remaining Shares of...: Press release article from: PR Newswire October 25, 2006 700+ words
...25 /PRNewswire-FirstCall/ -- AEterna Zentaris Inc. (TSX: AEZ; NASDAQ: AEZS...of Atrium Biotechnologies held by AEterna Zentaris by way of reduction of the stated capital of AEterna Zentaris' common shares. AEterna Zentaris...


AEterna Zentaris Shareholders Approve Reduction in Stated Capital and...: Press release article from: PR Newswire December 15, 2006 700+ words
...15 /PRNewswire-FirstCall/ -- AEterna Zentaris Inc. (TSX: AEZ; NASDAQ: AEZS...Biotechnologies Inc. (TSX: ATB) held by AEterna Zentaris at the special meeting of shareholders...shareholders, the board of directors of AEterna Zentaris determined that the distribution date...


AEterna Zentaris Enters a License and Collaboration Agreement with Spectrum...: Press release article from: PR Newswire August 12, 2004 700+ words
...All amounts are in Canadian dollars AEterna Zentaris Inc. (TSX: AEZ; Nasdaq: AEZS...The agreement comes on the heels of AEterna Zentaris regaining worldwide rights to D...Under the terms of the agreement, AEterna Zentaris granted to Spectrum an exclusive license...


AEterna Zentaris Strengthens its Position in the Development of Innovative...: Press release article from: PR Newswire January 6, 2005 700+ words
...Erucylphosphocholine (ErPC) AEterna Zentaris Inc. (TSX: AEZ; Nasdaq...At today's closing, AEterna Zentaris paid US$2.7 million by...443,905 common shares of AEterna Zentaris at US$6.11 per share...

For more facts and information, see all results

Source: HighBeam Research, Deal signed with Tulane for potential anticancer agents.

The AccessMyLibrary advertising network includes: